Imaging Assists Patient Selection
The ready availability of high quality CT-angiograms (CTA) and MRI/MRA not only allows for the identification of carotid stenosis in the symptomatic individual, but also factors highly in assessing the suitability for CEA or CAS. Either of these modalities allows for accurate assessment of stenosis, location of bifurcation, length of plaque, and intracranial collateral circulation. Most importantly for CAS, both modalities provide anatomical information about the aortic arch, common carotid artery, and the distal cervical internal carotid artery. For plaque specific features, CTA better predicts the degree of calcification, whereas MRI can detect potentially unstable intra-plaque hemorrhage. Difficult endovascular access, looping distal cervical internal carotid arteries, and highly calcified plaque have been proposed to increase the risk of perioperative complications following CAS.
The article by Almekhlafi et al 3 demonstrates that an experienced endovascular group can effectively provide CAS for stroke prophylaxis in the octogenarian population. We caution however, that CEA should be considered first, and if CAS is deemed to be more appropriate, then the treating physician should have a perioperative stroke and death rate approximating no more than 10%. Any future studies of CAS must prospectively account for age given the strong effect on perioperative risk.
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Incidence of symptomatic carotid stenosis rises steeply with age, and an increasing population life expectancy makes treatment decisions in the elderly more relevant today than when the landmark carotid endarterectomy (CEA) trials were conducted. With an approximate 37% stroke risk at two years 1 , the question is not whether to treat severe symptomatic stenosis in the elderly, but more appropriately whether to stent or operate. Carotid angioplasty and stenting (CAS) has evolved into a popular alternative to carotid endarterectomy for the treatment of carotid stenosis, particularly after publication of the largest randomized controlled trial (RCT) comparing the two procedures [Carotid Revascularization Endarterectomy versus Stent Trial (CREST)] 2 . Octogenarians however were excluded from this trial due to evidence suggesting that they are at increased risk with CAS. In this issue of the journal, Calgary investigators report on their experience with CAS in octogenarians 3 and they clearly wish to change this perception.
Carotid Artery Stenting in the Elderly
The CAS literature is replete with single centre case series and retrospective reviews. There are registries and industry supported studies with investigators from multiple disciplines looking at often-heterogeneous populations of symptomatic and asymptomatic patients. A common theme in many of the reports has been the dangers of this procedure in very elderly patients. The risk of major adverse effects, particularly stroke, death and myocardial infarction ranges from 2.1-25% [4] [5] [6] [7] [8] . A review of 11 studies totaling 933 octogenarians showed an overall stroke risk of 9% in this group. Elderly patients were particularly prone to significant hemodynamic depression following balloon angioplasty 4 . One of the largest CAS registries of almost 3,000 patients includes 322 octogenarians 9 . Compared to younger patients, their procedures were longer, more often associated with peri-procedural adverse events, and more likely to be aborted due to unfavourable anatomy. They had twice the risk of in-hospital stroke, death or transient ischemic attack. The authors believe that pooled registry data "clearly show increasing age to be an independent predictor of in-hospital death and stroke rates".
Information from RCTs of CAS vs. CEA has shown similar results. The association between advanced age and increased risk with CAS was seen in the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) trial, the International Carotid Stenting Study (ICSS) and the lead-in phase to CREST [10] [11] [12] . As patient selection, operator experience and technology improve, it has been shown that CAS can be done safely in octogenarian 13 , yet even interventionalists as experienced as the Calgary group report a 10.2% cumulative risk of stroke or death at 30 days.
